Follows initiation of Phase 1a/1b study in the U.S. Adcentrx intends to include clinical centers in China to broaden geographic representation and accelerate patient enrollment into the Phase 1a/1b study SAN DIEGO and SHANGHAI, June 8, 2026 /PRNewswire/ — Adcentrx Therapeutics…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
